CBDa Oil

Introducing Our 10x Gold CBDa and a little history.

This is actually pretty easy, pretty simple, and it's something you can all take and understand about CBD and CBDa.

That there is solid science behind what we're doing. And that the product that we're launching here the 10x Gold 1000. Is a showstopper and by the time I'm done you're going to understand why. So I have just really one product I'm going to focus on, and that is CBDa. I'm going to go through the reasons why CBDa is such an important product and it starts right here.

So we're going to start with the top thing an anandamide. Probably none of you ever heard of an anandamide, but all of you know what it is.

Women, if you've had a little chocolate. And you're feeling really good after the little bit of chocolate. An anandamide, is what's giving you that really good feeling. If you've been kicked in the shin and you're hurt. The relief of pain comes from an anandamide. When you have an infection, that's flowing through your body and causing pain. The relief of that pain is from an anandamide. So basically, we were gifted with this endorphin in our body. With this endocannabinoid in our body that serves to protect us. From the pain that we would otherwise be going through got. This pain relief endorphin, this pain relief endocannabinoid that is. Degraded into something. That's actually now going to cause more pain than it was relieving which is ironic.

So back in around 1970 something. One of the companies came up with a drug called ibuprofen. Ibuprofen was designed to block the conversion of an anandamide to prostaglandin. It did a good pretty good job of that, when most of you aren't old enough to know. But when ibuprofen first came out. It was actually promoted as an alternative to opiates. Because it's thought to be strong enough to relieve the pain and - and we could avoid opiates.

It didn't prove to be that good. Partly because you can't take enough of it to do it. There were, as I recall, about fifty nonsteroidal anti-inflammatory drugs on the market. All of which did pretty much the same thing until 1998, when Merck introduced Vioxx. Vioxx came and was the first of the drugs that was said to just affect the cox-2 pathway. So that you wouldn't have the interference with the cox-1 pathway.